Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2021-07-01 | Erich Mohr: CEO of MedGenesis Therapeutix; Chairman of Oak Bay Biosciences; qualifications include Industry, Leadership, Innovation. |
2022-04-26 | Dr. Mohr received a Ph.D. and M.Sc. from the University of Victoria, British Columbia, Canada, and a B.A. and B.Sc. from University of the Pacific. Dr. Mohr’s qualifications to serve on our Board of Directors include his experience in the healthcare industry, his business training and education, and his experience serving on multiple boards over the course of his career. |
Data sourced from SEC filings. Last updated: 2025-07-01